Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified

Table 2 Clinical characteristics and outcome of the patients with positive small bowel capsule

Case	Sex	Age	SBCE Findings	LS	Treatment pre-SBCE	Treatment post-SBCE	Diagnostic at follow-up
1	F	38	Multiple jejuno-ileal ulcerations	1404	5ASA	5 ASA + AZT	CD
2	F	18	Ulcer (n = 1) and edema of 3° tertile	143	AZT	Anti-TNF	CD
3	M	23	Ulcer (n = 1) and edema of 3° tertile	143	5ASA	5ASA	CD
4	F	20	Ulcerations (n = 2) and edema of 3° tertile	233	5ASA	5ASA	CD
5	F	33	Ulcer (n = 3) of 2° tertile	225	5ASA	5ASA	CD
6	F	19	Multiple ulcerations and edema of 3° tertile	908	5ASA	AZT	CD
7	M	60	Focal edema of 1° tertile	8	No treatment	5ASA	UC
8	M	22	Multiple jejuno-ileal ulcerations	2080	5ASA	5ASA + AZT	CD
9	F	32	Multiple ulcerations and edema of 3° tertile	908	5ASA	AZT	CD
10	F	27	Focal edema of 3° tertile	8	Prednisolone	anti-TNF	UC
11	F	47	Focal edema of 2° tertile	8	5ASA	5ASA	UC
12	F	31	Ulceration and edema of 1° (n = 5) and 2° tertile (n = 6)	879	5ASA+Prednisolone	AZT	CD
13	M	44	Focal edema of 3º tertile	8	5ASA	5ASA	UC

5ASA: Mesalamine; anti-TNF: Anti-tumor necrosis factor drug; AZT: Azathioprine; CD: Crohn’s disease; SBCE: Small bowel capsule endoscopy; LS: Lewis score; UC: Ulcerative colitis.